Plainsboro, NJ, United States of America

Pamela R Stergios


Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 52(Granted Patents)


Company Filing History:


Years Active: 2002-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Journey of Pamela R. Stergios

Introduction

Pamela R. Stergios, a prominent inventor based in Plainsboro, NJ, has made significant contributions to the field of pharmaceuticals. With three patents to her name, her innovations focus on enhancing the solubility and bioavailability of pharmaceutical formulations, particularly for sparingly water-soluble compounds.

Latest Patents

Her latest patent describes an aqueous solubility pharmaceutical formulation that involves converting a crystalline pharmaceutically active agent into its stabilized amorphous form. This formulation utilizes a solid solution of a normally hydrophobic vehicle, ensuring a long shelf life while also providing increased solubility and bioavailability. The unique composition stabilizes solutions of the active agent, preventing the recrystallization and precipitation of the less soluble crystalline form from aqueous solutions.

Career Highlights

Pamela R. Stergios has worked with notable companies such as R.P. Scherer Technologies, Inc. and FMC Corporation. Her work with these organizations has been instrumental in the advancement of pharmaceutical technologies, showing her dedication to innovation in the industry.

Collaborations

During her career, Pamela has collaborated with experienced professionals like Ronald S. Vladyka and David F. Erkoboni. These partnerships have further enriched her research and development efforts, contributing to the successful outcomes of her innovative projects.

Conclusion

Pamela R. Stergios continues to be a driving force in pharmaceutical innovations. Her patented technologies not only showcase her inventiveness but also hold promise for improving the efficacy of medications that rely on solubility challenges. As her career progresses, the pharmaceutical industry eagerly anticipates her future contributions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…